Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Aberrant DNA methylation of hypothalamic angiotensin receptor in prenatal programmed hypertension
Fumiko Kawakami-Mori, … , Takeshi Marumo, Toshiro Fujita
Fumiko Kawakami-Mori, … , Takeshi Marumo, Toshiro Fujita
Published November 2, 2018
Citation Information: JCI Insight. 2018;3(21):e95625. https://doi.org/10.1172/jci.insight.95625.
View: Text | PDF
Research Article Development

Aberrant DNA methylation of hypothalamic angiotensin receptor in prenatal programmed hypertension

  • Text
  • PDF
Abstract

Maternal malnutrition, which causes prenatal exposure to excessive glucocorticoid, induces adverse metabolic programming, leading to hypertension in offspring. In offspring of pregnant rats receiving a low-protein diet or dexamethasone, a synthetic glucocorticoid, mRNA expression of angiotensin receptor type 1a (Agtr1a) in the paraventricular nucleus (PVN) of the hypothalamus was upregulated, concurrent with reduced expression of DNA methyltransferase 3a (Dnmt3a), reduced binding of DNMT3a to the Agtr1a gene, and DNA demethylation. Salt loading increased BP in both types of offspring, suggesting that elevated hypothalamic Agtr1a expression is epigenetically modulated by excessive glucocorticoid and leads to adult-onset salt-sensitive hypertension. Consistent with this, dexamethasone treatment of PVN cells upregulated Agtr1a, while downregulating Dnmt3a, and decreased DNMT3a binding and DNA demethylation at the Agtr1a locus. In addition, Dnmt3a knockdown upregulated Agtr1a independently of dexamethasone. Hypothalamic neuron–specific Dnmt3a-deficient mice exhibited upregulation of Agtr1a in the PVN and salt-induced BP elevation without dexamethasone treatment. By contrast, dexamethasone-treated Agtr1a-deficient mice failed to show salt-induced BP elevation, despite reduced expression of Dnmt3a. Thus, epigenetic modulation of hypothalamic angiotensin signaling contributes to salt-sensitive hypertension induced by prenatal glucocorticoid excess in offspring of mothers that are malnourished during pregnancy.

Authors

Fumiko Kawakami-Mori, Mitsuhiro Nishimoto, Latapati Reheman, Wakako Kawarazaki, Nobuhiro Ayuzawa, Kohei Ueda, Daigoro Hirohama, Daisuke Kohno, Shigeyoshi Oba, Tatsuo Shimosawa, Takeshi Marumo, Toshiro Fujita

×

Figure 4

Effect of dexamethasone (Dex) on Agtr1a mRNA and DNA methylation of the Agtr1a promoter in the immortal mouse fetal PVN neuronal cell line, N39.

Options: View larger image (or click on image) Download as PowerPoint
Effect of dexamethasone (Dex) on Agtr1a mRNA and DNA methylation of the ...
(A) Real-time PCR of Dnmt1, Dnmt3a, Agtr1a, and Agtr1b mRNA following treatment for 6 days with vehicle (n = 6) or Dex (n = 6). (B) Quantitation of DNA methylation (by MeDIP) at the Agtr1a gene +15/+251 from the transcription start site in vehicle-treated or Dex-treated cells (each n = 8). (C) ChIP assays of DNMT1 (left) and DNMT3a (right) binding to the site +15/+251 relative to the TSS in vehicle-treated or Dex-treated cells (n = 9 and 10 in DNMT1, and n = 7 and 10 in DNMT3a, respectively). (D) siRNA against DNMT3a (n = 10) significantly decreased DNA methylation of Agtr1a relative to scrambled siRNA (n = 11). (E) Effect of Dex treatment on Agtr1a mRNA expression in cells transfected with siDnmt3a (control and Dex, n = 12 and 11, respectively) or scrambled RNA (control and Dex, n = 10 and 8, respectively). (A–C) Filled circles, vehicle-treated cells; open circles, Dex-treated cells. (D–E) Filled circle, cells treated with scrambled RNA; open circles, cells treated with siRNA against Dnmt3a. Data represent means ± SEM. *P < 0.05 (A–D) t test; (E) Kruskal-Wallis test with post hoc Dunn’s multiple comparison.

Copyright © 2022 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts